Medication info
Alendronate Plus D Tablets

Alendronate Plus D Tablets

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
White Life Science Co., Ltd.
Appearance
White to grayish-white oblong tablets
Packaging
4 tablets/box [(4 tablets/PTP×1)]
Approval status
Active

MFDS item code 201507818 · Approved 2015.11.23 · Insurance code 625202320

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3~5 years of treatment. Patients who discontinue treatment should be periodically reassessed for fracture risk. Other beverages or foods, including mineral water and barley tea, and medicines may reduce alendronate absorption (see “Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce alendronate absorption in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medicine reach the stomach promptly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking the medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with insufficient calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides one week's supply of vitamin D at 400 IU or 800 IU per day. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the following morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Administration to older adults (65 years and older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min), but administration of this medicine is not recommended for patients with severe renal impairment (creatinine clearance less than 35 mL/min) because there is insufficient clinical experience.
Child dose
Children and adolescents (under 18 years of age): Safety and efficacy in children and adolescents have not been established.

Ingredients

Manufacturer
White Life Science Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis in postmenopausal women and men.

How to take

Adult dose

Take 1 tablet of this medicine (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medicines (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years. The need for continued treatment should be reassessed periodically in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3~5 years of treatment. Patients who discontinue treatment should be periodically reassessed for fracture risk. Other beverages or foods, including mineral water and barley tea, and medicines may reduce alendronate absorption (see “Interactions”). Consuming food within 30 minutes after taking this medicine or at the same time may reduce alendronate absorption in the body and decrease its effect. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to help the medicine reach the stomach promptly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking the medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with insufficient calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this medicine provides one week's supply of vitamin D at 400 IU or 800 IU per day. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the following morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. Do not take 2 tablets on the same day. Administration to older adults (65 years and older): No dose adjustment is necessary. Administration to patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min), but administration of this medicine is not recommended for patients with severe renal impairment (creatinine clearance less than 35 mL/min) because there is insufficient clinical experience.

Child dose

Children and adolescents (under 18 years of age): Safety and efficacy in children and adolescents have not been established.

Precautions

This medication can irritate the upper gastrointestinal tract, leading to esophagitis, esophageal ulcers, and esophageal erosion. If such symptoms occur, discontinue the medication and consult a physician. Take this medication with a sufficient amount of water (170-230 mL), and do not lie down for at least 30 minutes after taking it. Additionally, this medication should not be administered to patients with delayed esophageal emptying or hypocalcemia. Caution is advised when using this medication in patients with upper gastrointestinal diseases such as gastritis, duodenitis, and ulcers. Adverse reactions such as abdominal pain, nausea, dyspepsia, constipation, diarrhea, headache, and musculoskeletal pain may occur during use, particularly if there is worsening bone, muscle, or joint pain, consult a physician. This medication may interact with calcium supplements, antacids, and some other medications, so a dosing interval of at least 30 minutes should be maintained. If pregnant or breastfeeding, consult a physician before use, and it is not recommended for children. It is not recommended for patients with severely impaired renal function. During the use of this medication, it is important to maintain adequate intake of calcium and vitamin D, and to engage in weight-bearing exercise and healthy lifestyle habits. In case of overdose, symptoms such as hypocalcemia, esophagitis, and gastritis may occur; in such cases, do not induce vomiting and visit a medical institution immediately. Finally, store this medication out of the reach of children and do not transfer it to another container.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, esophageal ulcer, vomiting, abdominal distension, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, dysgeusia, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, esophageal stricture, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, localized jawbone necrosis, joint swelling, low-energy fractures of the femoral head and other bones, dizziness, vertigo, pruritus, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, rhinopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is best to avoid direct sunlight and store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White to grayish-white oblong tablets

Package unit

4 tablets/box [(4 tablets/PTP×1)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.